An anticancer agent comprising a compound represented by the formula (I) [R1 represents hydrogen atom, hydroxyl group, a C1-6 alkoxy group and the like； R2 and R3 represents hydrogen atom, a halogen atom, a C1-6 alkyl group and the like； R4 represents hydrogen atom, a C1-6 alkyl group, a C1-6 alkylsulfonyl group and the like； R5 represents hydrogen atom or a substituent； represents a single bond or a double bond； R6 and R7 represents hydrogen atom, a C1-6 alkyl group and the like； R8 represents hydrogen atom, a C1-6 alkyl group and the like； A represents —O—, —S—, or —CH2—； D represents —C═ or —N═； X represents methylene group, —O—, or —CO—； Q represents —N═ or —C(R8)═； and Y represents a heterocyclic group or amino group], which shows a superior inhibitory activity against pim-1 kinase.
